These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6436858)

  • 1. A dramatic behavioral response to thyrotropin-releasing hormone following low-dose neuroleptics.
    Garbutt JC; Loosen PT
    Psychoneuroendocrinology; 1984; 9(3):311-4. PubMed ID: 6436858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response of borderline and schizotypal patients to small doses of thiothixene and haloperidol.
    Serban G; Siegel S
    Am J Psychiatry; 1984 Nov; 141(11):1455-8. PubMed ID: 6388363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacotherapy for patients with borderline personality disorder.
    Gunderson JG
    Arch Gen Psychiatry; 1986 Jul; 43(7):698-700. PubMed ID: 2872871
    [No Abstract]   [Full Text] [Related]  

  • 4. Development of melancholia during carbamazepine treatment in borderline personality disorder.
    Gardner DL; Cowdry RW
    J Clin Psychopharmacol; 1986 Aug; 6(4):236-9. PubMed ID: 3525615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of tranquilizers on borderline and schizotypal patients questioned.
    Rockland LH
    Am J Psychiatry; 1985 May; 142(5):665-6. PubMed ID: 3885764
    [No Abstract]   [Full Text] [Related]  

  • 6. Lack of effect of dopamine receptor blockade on the TSH response to TRH in borderline personality disorder.
    Garbutt JC; Loosen PT; Glenn M
    Psychiatry Res; 1987 Aug; 21(4):307-11. PubMed ID: 3114780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuation pharmacotherapy of borderline personality disorder with haloperidol and phenelzine.
    Cornelius JR; Soloff PH; Perel JM; Ulrich RF
    Am J Psychiatry; 1993 Dec; 150(12):1843-8. PubMed ID: 8238640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacotherapy of borderline personality disorder. Alprazolam, carbamazepine, trifluoperazine, and tranylcypromine.
    Cowdry RW; Gardner DL
    Arch Gen Psychiatry; 1988 Feb; 45(2):111-9. PubMed ID: 3276280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress in pharmacotherapy of borderline disorders. A double-blind study of amitriptyline, haloperidol, and placebo.
    Soloff PH; George A; Nathan RS; Schulz PM; Ulrich RF; Perel JM
    Arch Gen Psychiatry; 1986 Jul; 43(7):691-7. PubMed ID: 3521532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amitriptyline versus haloperidol in borderlines: final outcomes and predictors of response.
    Soloff PH; George A; Nathan S; Schulz PM; Cornelius JR; Herring J; Perel JM
    J Clin Psychopharmacol; 1989 Aug; 9(4):238-46. PubMed ID: 2768542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacotherapy of borderline outpatients.
    Zanarini MC; Frankenburg FR; Gunderson JG
    Compr Psychiatry; 1988; 29(4):372-8. PubMed ID: 3409692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paradoxical effects of amitriptyline on borderline patients.
    Soloff PH; George A; Nathan RS; Schulz PM; Perel JM
    Am J Psychiatry; 1986 Dec; 143(12):1603-5. PubMed ID: 3538914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The dexamethasone suppression and thyrotropin-releasing hormone tests in depressed borderline patients.
    Sternbach HA; Fleming J; Extein I; Pottash AL; Gold MS
    Psychoneuroendocrinology; 1983; 8(4):459-62. PubMed ID: 6425891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The TRH test in patients wih borderline personality disorder.
    Garbutt JC; Loosen PT; Tipermas A; Prange AJ
    Psychiatry Res; 1983 Jun; 9(2):107-13. PubMed ID: 6413992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of phenelzine and haloperidol in borderline personality disorder.
    Soloff PH; Cornelius J; George A; Nathan S; Perel JM; Ulrich RF
    Arch Gen Psychiatry; 1993 May; 50(5):377-85. PubMed ID: 8489326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pathologic personality, temperament and treatment].
    Akiskal HS
    Encephale; 1995 Mar; 21 Spec No 2():47-9. PubMed ID: 7588180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positive effects of carbamazepine on behavioral dyscontrol in borderline personality disorder.
    Gardner DL; Cowdry RW
    Am J Psychiatry; 1986 Apr; 143(4):519-22. PubMed ID: 3513634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treating the borderline patient with low-dose neuroleptics.
    Frances A; Soloff PH
    Hosp Community Psychiatry; 1988 Mar; 39(3):246-8. PubMed ID: 3356429
    [No Abstract]   [Full Text] [Related]  

  • 19. Benzodiazepines in the treatment of depressive, borderline personality, and schizophrenic disorders.
    Schatzberg AF; Cole JO
    Br J Clin Pharmacol; 1981; 11 Suppl 1(Suppl 1):17S-22S. PubMed ID: 6133529
    [No Abstract]   [Full Text] [Related]  

  • 20. Alprazolam-induced dyscontrol in borderline personality disorder.
    Gardner DL; Cowdry RW
    Am J Psychiatry; 1985 Jan; 142(1):98-100. PubMed ID: 2857071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.